Signed into law 44 years ago...

The Government's
Secret Bailout

It's not autos, it's not banks and it's not energy. In fact, part
of this money ($1 Trillion per year) is going to a group of 12 publicly- traded companies you've likely never heard of – each one required by law to pay nearly all of it back to you...

(Deadline to Enroll for Next Payout: March 18th)

Dear Reader,

$800 billion to bail out a few banks?

Peanuts.

The real boondoggle has been going on under our noses for the last 44 years...

A $1 TRILLION a year government giveaway that's making a small group of companies (and their investors) rich.

Take Sarah Roads, for example...

A healthcare worker from Chicago, Sarah recently collected over $22,000 in one day thanks to the government's secret bailout. She stands to collect even more in the weeks to come.

Amazingly, she's been doing this all year.

Adam Gold is another example. The 55-year-old San Diegan has been cashing in on this opportunity since 2004. In 2008, he pocketed $114,927.  

Then there's Patty Bennett. She could easily retire and live solely off the income she's getting from this government-sponsored windfall.

Today, she's averaging about $3,416 a week. That's over $177,000 a year.

The list goes on and on...

And the most amazing thing is...  

In just a few weeks, they'll all get paid again.

It's no wonder Charles Wolpoff, tax attorney and writer for the Baltimore Business Journal calls the government's secret bailout "an excellent source for income. You can get... huge returns."

Or why The Wall Street Journal calls it "the antidote for queasy investors seeking safe havens during  a stomach-turning economic environment.”

In short, thanks to this unrivaled (though largely unnoticed) government handout, ordinary American citizens like you and me are entitled to receive regular cash distributions, several times a year.

And you're entitled to these payouts (which could conservatively reach over $110,000 the next few years, as I'll show you) regardless of your age or income status – and even if you're already retired.

The only thing you have to know is how to get involved.

In fact, you can get in on this opportunity today... and start collecting thousands of dollars in extra income as soon as March 31st.

But in order to receive this payout you must get in by March 18th.

Here's what you need to know...

While the Rest of the Market Tanks...
You Get Steady Income

Since the beginning of the year, when the financial crisis really took hold, stocks, bonds – everything – has gotten crushed.

The S&P alone has plummeted 40%.

Meanwhile, during that same stretch of time, many Americans were collecting thousands of dollars of worry-free income.

Regardless of how bad the economy gets... regardless of how bad the market gets... you get paid.

How much could you personally receive?

The sidebar to the right gives you some idea. Keep in mind, these are one-
day payouts.

So you might be wondering...

How is this possible? And why haven't I heard about this before?

The answer is pretty simple...

But first, you should know: Unlike the new bailout plan (that's really only
helping out a bunch of rich CEOs) the money from this "secret bailout,” as I like to call it, is available to everyone.

So long as you're an American citizen, you can start collecting the benefits
of this bailout right away.

The other thing you should know is that this program has been around for
nearly half a century.

And barring a complete overhaul of our federal government, it will still be
here 100 years from now.

How can I be so sure?

Let me explain...

An American Boondoggle Since 1965

1965 was a good year for American retirees...

In the fall of that year, Lyndon Johnson codified a program that Harry Truman had spent his entire political career trying to create:

Medicare.

On the surface, it's hard to see what Medicare has to do with your finances. Most of us have never even used it.

But the true gift of this program (as it concerns you and me) is this:

From that day on, the entire healthcare system essentially became a state-run, government-subsidized business.

Before that, healthcare was a private enterprise. If you couldn't afford insurance, you paid out of pocket. If you couldn't pay out of pocket, you didn't go to the doctor.

Now, hospital operators were collecting millions of dollars in Federal handouts every year to treat people that couldn't otherwise pay.

Eventually, the program was expanded to include speech therapy and chiropractic work. Then government employees became eligible, regardless of salary. And soon enough, prescription drugs were being paid for as well. 

Today, the healthcare industry receives $1 TRILLION a year from the government.

No other industry in America gets that much support – not even close.

And it's precisely because of this mammoth government handout that you could collect a ton of money, every month, for the rest of your life...

Why You've Probably Never Heard of the Biggest Government Giveaway Ever...

You see, every cent of this money comes from Americans like you and me – anyone who's ever paid taxes.

And in exchange for this $1 trillion handout, the government requires that a big chunk of that money gets back to us. 

In fact, these cash distributions are mandated by Federal law. 

As long as this law is on the books, anyone who takes advantage of it is entitled to this money.

And there's really no limit to how much you could collect.

If you're wondering why your financial advisor or your accountant has never mentioned this before – there are a couple reasons:

For one, these payouts don't come straight from the government. There are no tax forms to fill out at the end of the year – no deductions to claim.

Instead, the money comes directly from a very small group of companies (there are only 12 in the world) that receive the biggest government handouts.

Unless you know which ones to look for, you'd never notice the windfall...

Secondly, the few businesses that are involved in this program are all but unknown to most Americans.

These aren't the high-profile drug giants like Merck and Pfizer. They're not even the lesser-known hospital operators like Tenet.

But, as I'll show you, they're arguably the most vital component of the entire industry...

In fact, without these businesses, companies like Merck and Pfizer might not exist – not to mention your local hospital... or your doctor's office...

Which just might explain why these businesses are so heavily subsidized in the first place...

Just what kind of subsidies am I talking about? And what does it mean for you?

Let me explain...

How Healthcare's Secret Businesses Could
Pay for Your Retirement

Just like the healthcare industry itself, a big portion the money these companies make comes straight from government subsidies.

Last year alone, one of these companies received over $150 million (a full one-third of their revenue) from the government.

But that's just for starters...

By law, these companies can claim up to 100% of their income tax free.

They don't have to pay any capital gains tax either. In fact, they hardly pay any taxes at all.

Then there's the Certificate of Need Laws – also known as the CON Laws. This Reagan-era piece of legislation restricts the number of companies that can operate in any one region – thus limiting competition.

In other words, in many places, these companies operate a near monopoly.

Why all the government favors? It will soon become clear. Right now, it's important to know this:

In exchange for this rich government protection (and healthy funding), these businesses are required, by law, to give a big chunk of that money back to U.S. citizens in the form of regular, cash distributions.

Claiming your share is simple. You just have to know which companies are making payouts – and when.

The trick is, unless you're part of the medical community, you probably don't even know these companies exist...

You see, most people never give it a second thought...

When you go to the doctor, the hospital, the physical therapist, you're probably not thinking about who owns the building you're sitting in... or the land that building is on...

Truth is, it's not the doctor that's treating you... or even the hospital that employs them...

In most cases, that building and that land are owned by the heavily-subsidized companies I've been talking about – companies known in the industry as Healthcare Trusts.

Virtually every square foot of medical space in America, every acre of land, is owned by these twelve Trusts.

And I'm not just talking about doctor's offices and hospitals. I'm talking about nursing homes, retirement centers, drug manufacturing plants, biotech research labs, clinics, mental health facilities... anything that has to do with medicine and healthcare.

Just to be clear: These companies have nothing to do with making drugs or healing the sick. They don't employ doctors or scientists. 

All they do is own the land and buildings. Then, through long-term leases and contracts, they rent that land and those buildings to healthcare, pharmaceutical and biotech companies.

For example...

One of these companies owns 30 research facilities, including over 5 million
square feet of lab space operated by biotech giants Amgen and Genentech.

(If you owned just 2,000 shares of this company since it went public, you
would have collected over $133,000 by now.)

Another owns major hospital systems in Chicago, Boston, Denver,
Phoenix, Las Vegas, Houston, Tucson, Detroit, New Orleans, San Diego,
Indianapolis and L.A.

(And a $5,000 investment in this company at the beginning of 2000
would be worth $56,000 today.)

Still another owns 189 nursing homes from Salem, Oregon to Sunrise, Florida (and has returned 436% in that same time period).

That's just scratching the surface...

Quite literally, these Trusts "own" practically the entire healthcare industry.

Can you imagine if one of these companies went under? How about two, or three? What if they decided to liquidate all their property?

It's no exaggeration to say our country's healthcare system would be crippled – and the consequences would be devastating.

That's why the government continues to pump billions of dollars into these companies, every single year.

It's also why this government bailout could realistically fund your retirement, starting today.

Let me show you exactly how it works... and exactly how much you could make in the next 12 months...

How to Get Paid (Thousands of Dollars)
Every Month

All of these Trusts are publicly traded.

To claim your share of the payouts, there's only one requirement: You have to be a shareholder.

Anyone who owns at least one share is entitled to cash payouts every few weeks. You don't even have to be a long-term investor in the company. As long as you sign up before the payout is announced, it's yours.

You can even sell your shares the very next day and keep the cash.

But you probably won't want to...

Because as long as you're a shareholder, you're entitled to these regular cash distributions by law... for as long as the Trust exists.

How much of this money you personally receive is entirely up to you. The more money you put in, the more you get back...

For example...

One of these Trusts just paid out $2.70 for every share.

If you owned 1,000 shares, you would have collected $2,700. If you owned 3,000 shares, you would have collected $8,100. Five thousand shares would have gotten you $13,500.

That's cash, in your pocket. And that's regardless of what's going on with the economy, the stock market or anything else.

The Trust portfolio we recently put together is comprised of the three biggest Trusts in the industry today.

The worst-performing Trust in this group has returned 322% since January 2000. By comparison, the stock market as a whole (as measured by the S&P 500) is down over 40%.

Even more impressive: If you owned just 3,000 shares of each of these companies, you would have received $110,992 over the last five years.

And best of all, each one of these Trusts has historically kept a different quarterly payout schedule.

Just take a look:

That means, by investing in all three, you'll likely receive a check every month next year.

When you put it all together, I think this is the safest, easiest, most lucrative way to ensure an early, worry-free retirement. Remember, these companies are required, by law, to make these payouts. And as long as they are, you'll get cash delivered to your doorstep once a month...

If this sounds like something you'd like to be a part of, we've just written a full report detailing the entire situation. It's called "The Government's Secret Bailout: Using Healthcare Trusts to Fund an Early Retirement."

In this report, you'll learn everything you need to know to start collecting monthly checks courtesy of the government – including when you can expect them... how much you'll receive every month... and how much you can expect to make over the next few years.

The next payout is due on March 31st.

But in order to receive it, you must get in by March 18th.

Here's how to get your copy...

How to Quadruple Your Portfolio

My name is George Rayburn. I'm the Executive Publisher of Stansberry & Associates.  

When we started our company back in 1999, we weren't very well known. We published only one investment letter and we had a few hundred subscribers.

Today, we publish more than a dozen. Our work reaches bankers, hedge fund managers, and CEOs in more than 130 countries worldwide.

I've been here for a long time, so I have a pretty good idea what's made us so successful. It's simply this:

When we hire analysts, we look for men and women who are experts in their field.

For example, when we decided to start publishing an investment advisory about oil, we didn't look for some Harvard MBA who was good at crunching numbers. We hired a geologist with over 10 years experience in the oil industry – a guy who spent most of those years in the field... touring potential new wells... evaluating seismic data... and working on deepwater rigs...

You've probably read some of Matt Badiali's work in The Growth Stock Wire.

Likewise, when we started our options advisory letter, we hired a man who had spent his entire career as a professional options trader – Jeff Clark.

Our income specialist, Tom Dyson, was formerly a bond-trader at Citigroup. Our value-investing specialist, Dan Ferris, was recently profiled in Barron's as one of the best value analysts in America.

But what we're most proud of is how we've helped many people change their lives, by showing them how to safely make more money than they ever imagined possible.

For example...

A subscriber named Jack Marks, from Pittsburgh, wrote to tell us he made 340% on a recent recommendation. He added: "I suppose... a house in Hilton Head may still be in the cards for me."

A subscriber named Clyde Lafond, 68, from Burbank, CA, wrote to tell us: "My $600,000 is now worth well over a $1,000,000. I think that I am almost ready to retire."

A subscriber and retired cardiac surgeon named R. C. Beck recently told us: "I took my wife's portfolio from her advisor and quadrupled it."

A few years ago, we hired Rob Fannon – one of the most well-connected medical insiders in America.

To say Rob's seen every side of this industry is an understatement. He's worked on lab projects for the U.S. government. He's done cancer research at one of the most prestigious hospitals in the world. He helped set up a biotech firm in Asia.

Today, Rob works for us, writing an independent investment advisory called Phase 1 Investor. In it, he routinely covers the world's most innovative new medical technologies... scientific procedures... and breakthrough medicines...

But what really sets Rob's work apart are the opportunities he uncovers that only a true medical insider could know about – opportunities like the government's secret bailout.

I don't think anyone else – anyone who didn't have Rob's years of field experience combined with years of market analysis – could have discovered such an amazing income opportunity...  

And there's no reason why you can't start using this strategy yourself right now... to ensure an early, worry-free and rich retirement.

That's why I want to send you his special report called "The Government's Secret Bailout: Using Healthcare Trusts to Fund an Early Retirement."

If we were going to sell this report on its own, I'd demand we charge at least $10,000 for it.

Frankly, I think we could charge a lot more.

You could easily make that much in just one day's worth of payouts.

But because you're already a subscriber to S&A Research, I'd like to give you a much, much better deal. 

To receive a copy of Rob's repot, all I ask in return is you give Phase 1 Investor a three-month, risk-free trial.

I'll tell you more about Phase 1 in a minute.

But before I do, I'd like to tell you about another great investment opportunity Rob recently uncovered, thanks to his unique, insider experience...

How to Be Right (and Make Money on it) 99.99% of the Time

Most people know about the outstanding fortunes a breakthrough drug can bring...

Not just for the company that made it – but for the investors that put their money on it while it was still in the early stages of testing.

Here are just a few examples...

That's just skimming the surface...

The catch is, for most of us, betting on biotech is a risky venture...

As I'm sure you know, the majority – the vast majority – of potential new drugs fail to get FDA approval. In fact, only 1 in 10,000 new drug candidates actually pass.

So while success can bring instantaneous wealth... it's nearly impossible to come by.

But what most people don't know is this:

There's actually a way you can make a fortune investing in new drugs... even when they fail...

And I'm not talking about shorting drug stocks or buying "put options."

I'm talking about owning an investment that's all but unknown outside the medical community...

A company that actually succeeds whether a new drug – any new drug – passes or fails its FDA tests. 

Just consider that for a moment...

By betting on a new drug to become the "next big thing," you have a 1 in 10,000 chance of being right. But by betting on a new drug to fail, you'll be right 99.99% of the time.

Either way, there's an investment you can make that stands to profit in either scenario – pass or fail, it doesn't matter. 

Nothing is guaranteed in the investing world... but I don't know of anything that comes this close.

What exactly am I talking about?

Let me explain...

300% Gains from the Most Carefully
Guarded Secret in Biotech

You might be surprised, but most biotech and Big Pharma companies – from giants like Amgen to the firms you've never heard about – don't run their own drug tests.

There's a whole other realm of medical companies that do it for them – companies that specialize in drug research.

These testing firms find doctors, recruit participants, run the tests and compile the data.

They have no financial ties to the drug itself – or the company that made it... other than the fact that they get paid whether that new drug passes or fails its tests.

Let me say that again: All these companies do is test new drugs. And they
make money no matter what the result.

The way I see it, let other people gamble on whether a new drug will succeed. I'd rather take the sure thing – by investing in these testing companies – and get paid every time a new drug is tested.

Now here's what's most exciting:

Today, there are only two companies in the entire United States that dominate this field. One of these companies specializes in "early-stage tests" (Phases 1 and 2). The other specializes in "late-stage tests" (Phase 3).

If a new drug is going through the FDA approval process, chances are one of these two companies – or both – is doing the testing.

So it's no surprise that these companies are virtual cash machines for shareholders. Since January 2000, one of these companies has returned nearly 300%. The other has returned over 750%.

And there's no sign whatsoever of a slow-down...

Drug companies spent about $73 billion on research and development in 2006. A full 21% ($15 billion) of this was outsourced to the drug testing industry.

That number is expected to double next year .

As Barron's reports: "Demand [for these testing services] is on the rise. More drugs are now in development and need testing, and big drug makers, including Pfizer and Johnson and Johnson are outsourcing development-related work to cut costs and speed along drug approvals."

What it all boils down to is this: If you want a simple and safe way to make a fortune over the next few years as more and more drugs get tested, this is the best way to do it.

There's no guarantee as to how many drugs will get approved each year – but we do know that every drug will be tested.

And the companies that provide these services will keep profiting exponentially as a result. 

Rob's written a special report to help you take advantage of this situation immediately. It's called: "How to Make a Fortune Investing in New Drugs – Even When They Fail."

When you take a three-month trial subscription to Phase 1, you'll receive a copy of this report as well, free of charge.

How will you know if Phase 1 is right for you?

Let me tell you more about it, so you can decide for yourself...

Why Connections Make all the Difference...

I mentioned earlier how Rob Fannon has an MBA and Masters in Public Health from Johns Hopkins University. How he's worked in the lab of one of America's best hospitals, and even helped set up a biotech firm in India.

What I didn't mention is that soon after we hired him, he insisted on hiring one of the men he met at Hopkins as his analytical assistant. His name: Dr. George
Huang.

Dr. Huang got his PhD from the Hopkins School of Medicine, studying under a 2003 Nobel Laureate in Chemistry. Before working for us, he worked for a biotech firm in Canada. He speaks three languages... and has been published in the four leading journals of his field.

Since joining our team, these two men have used their experience – and treasure trove of connections – to find some of the greatest medical investments in the markets today. For example...  

From his work in genetics, Rob told us about a radical new medical treatment called RNAi, which is being used to treat several major disorders. After consulting with Dr. Judy Lieberman — a Professor of Medicine at Harvard University... and a patent attorney, Rob added an RNAi company called Sirna to his portfolio. Just 6 months later, it was bought out by Merck — and the stock DOUBLED OVERNIGHT. Those who got in at our original recommendation, made 203% gains.

Likewise, Rob's connections with world-famous heart doctor P.K. Shah at Cedars-Sinai Hospital led us to recommend a company called Esperion, which developed a new way to treat heart disease. Rob worked in a lab down the hall from Shah, who was involved in early research that went into the company. Three weeks after we recommended Esperion, the stock jumped 55% overnight, when it was bought by Pfizer.

Rob used his connections at Johns Hopkins to learn about a new vaccine technology which is being licensed by dozens of big companies. In fact, Rob even set up a meeting between the company behind it (called Crucell) and the University. Since we recommended Crucell, our readers have had the chance to make gains of 292%. 

Needless to say, the response from our readers has been incredible.

Here are just some of the comments we've received:   

When you take a no-risk-trial subscription to Phase 1, you'll receive:

Here's how to get started...

Take the next 3 months, No Obligation...

When you sign up for a trial subscription to Phase 1, you will have the next three (3) months to decide if it's right for you. 

We want you to be happy with our work. And there's no sense doing business together if you're not. That's why you can try Phase 1 for the next three months at no risk.

If you're not happy for any reason, simply let us know and we'll promptly send you a full refund, 100%.

As I mentioned before, I'd ask for no less than $10,000 if we were selling this research on its own. But as a current S&A member, you won't pay half that much...

You won't even pay a third that much...

For agreeing to take a no-risk trial to Phase 1 today, I'd like to give you everything I've mentioned in this letter – 12 months of Rob's Phase 1 research and his two special reports – for $2,600.

Remember, the next payout from the government's secret bailout is due in just a few days – a payout that could easily cover this cost many times over.

And also keep in mind... you'll have the next three months to look over Rob's work and decide if it's right for you.

If not, no problem.

To get started right away, Subscribe Now

Sincerely,

George Rayburn
Executive Director, S&A Investment Research
February 2009

P.S. This special $2,600 price is good only through this invitation – and only for a limited time. To get started right away...

Subscribe Now